LAGI, FILIPPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.910
AS - Asia 3.378
EU - Europa 2.969
SA - Sud America 361
AF - Africa 90
OC - Oceania 42
Totale 10.750
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.851
RU - Federazione Russa 1.322
SG - Singapore 1.051
CN - Cina 1.046
IT - Italia 544
HK - Hong Kong 400
KR - Corea 315
BR - Brasile 279
PL - Polonia 254
VN - Vietnam 234
IE - Irlanda 161
DE - Germania 144
FR - Francia 130
SE - Svezia 120
FI - Finlandia 98
GB - Regno Unito 86
IN - India 78
BD - Bangladesh 53
JO - Giordania 47
ID - Indonesia 42
AU - Australia 41
AR - Argentina 33
NL - Olanda 29
CA - Canada 28
JP - Giappone 25
ES - Italia 20
ZA - Sudafrica 19
MX - Messico 18
NG - Nigeria 16
UA - Ucraina 15
CH - Svizzera 13
EC - Ecuador 13
PK - Pakistan 13
CO - Colombia 10
TR - Turchia 10
BJ - Benin 9
CL - Cile 9
IQ - Iraq 9
UZ - Uzbekistan 9
CI - Costa d'Avorio 8
PY - Paraguay 8
RO - Romania 8
EG - Egitto 7
VE - Venezuela 7
ET - Etiopia 6
KE - Kenya 6
PH - Filippine 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 4
JM - Giamaica 4
LT - Lituania 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
SA - Arabia Saudita 4
AT - Austria 3
AZ - Azerbaigian 3
DZ - Algeria 3
LV - Lettonia 3
OM - Oman 3
TW - Taiwan 3
AM - Armenia 2
CG - Congo 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
IR - Iran 2
LU - Lussemburgo 2
PA - Panama 2
QA - Qatar 2
SY - Repubblica araba siriana 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
MK - Macedonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
YT - Mayotte 1
Totale 10.750
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.051
Singapore 794
Ashburn 707
Hefei 376
Hong Kong 347
Seoul 311
San Jose 273
Warsaw 248
Dublin 161
Florence 129
Fairfield 126
Chandler 109
Dallas 99
Beijing 95
Los Angeles 86
Moscow 81
Munich 78
Hanoi 65
New York 65
Buffalo 63
Council Bluffs 63
Lauterbourg 63
The Dalles 63
Ho Chi Minh City 59
Helsinki 57
Kent 56
Altamura 50
Lawrence 50
Milan 43
Seattle 43
Houston 40
Melbourne 39
Woodbridge 39
Wilmington 38
Mumbai 35
Paris 35
Cambridge 34
Jakarta 33
Princeton 31
London 28
São Paulo 26
Rome 25
Tokyo 24
Boston 21
Turku 21
Shanghai 20
Bengaluru 17
Chicago 17
Guangzhou 16
Medford 16
Abuja 15
Frankfurt am Main 15
Lappeenranta 15
Orem 15
San Diego 14
Ann Arbor 12
Brooklyn 12
Denver 12
Montreal 12
Poplar 12
West Jordan 12
Naples 11
Phoenix 11
Redondo Beach 11
Tianjin 11
Johannesburg 10
Madrid 10
Rio de Janeiro 10
Yubileyny 10
Bern 9
Cotonou 9
Da Nang 9
Abidjan 8
Chennai 8
Dearborn 8
Nuremberg 8
Tashkent 8
Washington 8
Bari 7
Falkenstein 7
Haiphong 7
Hải Dương 7
Manchester 7
Shenzhen 7
Stockholm 7
Timisoara 7
Belo Horizonte 6
Clifton 6
Dong Ket 6
Düsseldorf 6
Nairobi 6
Pistoia 6
Toronto 6
Amman 5
Amsterdam 5
Andover 5
Atlanta 5
Barnet 5
Elk Grove Village 5
Manaus 5
Totale 6.804
Salva come PNG Salva come JPEG
Nome #
Proposal for a New Score-Based Approach To Improve Efficiency of Diagnostic Laboratory Workflow for Acute Bacterial Meningitis in Adults 451
Imported dengue fever in Tuscany, Italy, in the period 2006 to 2012. 245
Antibodies Induced by Smallpox Vaccination after at Least 45 Years Cross-React with and In Vitro Neutralize Mpox Virus: A Role for Polyclonal B Cell Activation? 214
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 197
Latent Tuberculosis Infection and COVID-19: Analysis of a Cohort of Patients from Careggi University Hospital (Florence, Italy) 193
Implementing Early Phase Treatments for COVID-19 in Outpatient Settings: Challenges at a Tertiary Care Center in Italy and Future Outlooks 191
Male reproductive system inflammation after healing from coronavirus disease 2019 190
Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study 189
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 186
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 182
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy 181
Characteristics of COVID-19 vaccinated and unvaccinated patients admitted to Careggi University Hospital, Florence, Italy 179
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 179
Early discharge criteria in patients with acute bacterial skin and skin structure infections in a large tertiary-care teaching hospital in Florence, Italy 179
Arbo-score: A rapid score for early identification of patients with imported arbovirosis caused by Dengue, Chikungunya and zika virus 176
Reply: COVID-19: Semen impairment may not be related to the virus 176
Treatment with anti-SARS-CoV-2 monoclonal antibodies in pregnant and postpartum women: first experiences in Florence, Italy 175
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience 174
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 168
Can SSRI/SNRI antidepressants decrease the 'cytokine storm' in the course of COVID-19 pneumonia? 166
Emergence of dengue fever: sentinel travellers uncover outbreak in Sharm El-Sheikh, Egypt, May 2024 165
Cancer population may be paradoxically protected from severe manifestations of COVID-19 165
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19 165
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 164
Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 163
Facilitators and barriers in HIV testing and continuum of care among migrant transgender women who are sex workers residing in Florence, Italy 160
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes: implications for booster strategies 159
Diagnostic accuracy of physician’s gestalt in suspected COVID-19: Prospective bicentric study 159
When it rains, it pours: Early treatment with tecovirimat of cardiac complications associated with monkeypox infection in a person with HIV and previously undiagnosed Lyme disease. A case report 157
The prognostic role of IL-10 in non-severe COVID-19 with chemosensory dysfunction 155
Tubercular prosthetic joint infection: two case reports and literature review 151
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort study 149
DYNAMIC OF TRANSMISSION AND ACQUISITION OF HIV AMONG MIGRANTS FROM PERU LIVING IN FLORENCE: IMPLICATIONS FOR EFFECTIVELY MANAGING HIV PREVENTION AND RETENTION PROGRAMMES 147
Babesiosis in the immunocompromised population: Results from a multicentric cohort study conducted in Italy 143
High-dose steroids for the treatment of severe COVID-19 143
The never-ending story of mpox epidemic: Tracing a new cluster in Florence, Italy 140
Continuum of care among HIV-1 positive patients in a single center in Italy (2007–2017) 140
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH) 140
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort) 139
Leptospirosis acquired by tourists in Venice, Italy 137
Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study 134
Comparison of the efficacy, safety and durability of a switch to co-formulated RPV/TDF-TAF/FTC or DTG/ABC/3TC in virologically-suppressed HIV-1-infected patients in a single Italian centre: a cohort data analysis 133
Procalcitonin for the differential diagnosis of COVID-19 in the emergency department. Prospective monocentric study 129
Use of colistin in adult patients: A cross-sectional study 128
Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 128
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients 128
Efficacy and safety of Pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review 126
The burden of clostridioides difficile infection during the COVID-19 pandemic: A retrospective case-control study in Italian hospitals (CloVid) 125
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 123
Prospective study on incidence, risk factors and outcome of recurrent clostridioides difficile infections 122
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 120
Impact of rapid-antiretroviral therapy in a cohort of treatment-naïve migrants living with HIV in a high income setting 114
Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 113
Clinical role of viral identification by a polymerase chain reaction-based diagnostic panel in adults hospitalized with community-acquired pneumonia 112
Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV 111
Imported dengue fever in Tuscany, Italy, in the period 2006 to 2012. 110
Overall Tolerability of Integrase Inhibitors in Clinical Practice: Results from a Multicenter Italian Cohort 109
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 107
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients 107
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study 107
Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriales infection: are they the same in neutropenic and non-neutropenic patients? 107
UNAIDS 90-90-90 Target and Retention in Care of a Cohort of Migrants Living with HIV in a Tertiary Referral Hospital in Florence, Italy 106
Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort 105
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 104
Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort 104
Incidence of hypoglycaemia associated with transient loss of consciousness. A retrospective cohort study 102
Viro-immunological efficacy and tolerability of dolutegravir-based regimens compared to regimens based on other integrase strand inhibitors, protease inhibitors or non-nucleoside reverse transcriptase inhibitors in patients with acute HIV-1 infection: A multicenter retrospective cohort study 96
Malattie Tropicali Neglette in un'area non endemica, la casistica del Centro di Riferimento della Regione Toscana per lo Studio e la Cura delle Malattie Tropicali (1999-2013) 90
Monkeypox: A novel pitfall in clinical dermatology 89
Transgender people living with HIV: characteristics and comparison to homosexual and heterosexual cisgender patients in two Italian teaching hospitals 89
VIRO-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice 88
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study 82
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study 75
Serology-Based Screening and Prevalence of Schistosomiasis, Strongyloidiasis, and Chagas Disease in Migrants Living with HIV: Results from a 10-Year Retrospective Cohort in an Italian Tertiary Healthcare Center 55
Durability of Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV) 42
Exploring mpox vaccination uptake and tolerability among people living with HIV: A study in an infectious disease unit in Italy 24
Screening for Leishmania spp. infection in patients treated with biologic agents for immune-mediated inflammatory diseases: results of an Italian multicentric prospective study 22
Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: real-world data from the PRESTIGIO Registry 18
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry 18
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era 10
Totale 10.844
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 0 15 36
2021/2022229 10 17 13 10 4 24 4 28 5 13 32 69
2022/2023723 45 151 44 20 26 120 100 43 88 13 53 20
2023/2024687 21 41 68 30 46 88 21 170 24 99 52 27
2024/20253.731 130 356 217 627 934 440 115 167 195 123 167 260
2025/20264.841 588 739 723 461 575 164 559 197 282 334 219 0
Totale 10.844